n | Pre-injury EQ-VAS assessed at T1 (1 week post-injury) | Pre-injury EQ-VAS assessed at T2 (12 months post-injury) | P-value | ICC | |
---|---|---|---|---|---|
Total | 1132 | 82.9 (SD 15) | 84.4 (SD 14) | 0.001* | 0.580 (0.54, 0.62) |
Gender | |||||
Males | 596 | 85.1 (SD 14) | 85.8 (SD 13) | 0.191 | 0.580 (0.53, 0.63) |
Females | 536 | 81.3 (SD 16) | 83.3 (SD 15) | 0.001* | 0.571 (0.51, 0.63) |
Age | |||||
< 65 years | 564 | 86.4 (SD 13) | 86.9 (SD 14) | 0.324 | 0.564 (0.51, 0.62) |
65+ years | 568 | 80.3 (SD 16) | 82.4 (SD 15) | 0.000* | 0.565 (0.51, 0.62) |
Educational level | |||||
Low | 295 | 79.1 (SD 16) | 81.4 (SD 15) | 0.007* | 0.548 (0.47, 0.62) |
Middle | 439 | 84.2 (SD 16) | 85.7 (SD 14) | 0.021* | 0.603 (0.54, 0.66) |
High | 373 | 86.3 (SD 12) | 86.6 (SD 12) | 0.582 | 0.585 (0.52, 0.65) |
Unknown | 25 | 74.0 (SD 16) | 75.2 (SD 20) | 0.798 | 0.142 (−0.24, 0.48) |
Comorbidity status | |||||
No comorbidity | 486 | 89.7 (SD 12) | 90.0 (SD 10) | 0.168 | 0.423 (0.35, 0.49) |
Comorbidity | 628 | 78.4 (SD 15) | 80.4 (SD 16) | 0.083 | 0.557 (0.50, 061) |
Unknown | 18 | 84.9 (SD 11) | 87.4 (SD 12) | 0.111 | 0.353 (−0.09, 0.69) |
Injury Severity Score | |||||
ISS < 16 | 1060 | 83.2 (SD 15) | 84.6 (SD 14) | 0.001* | 0.582 (0.54, 0.62) |
ISS > =16 | 64 | 87.4 (SD 13) | 87.4 (SD 14) | 0.991 | 0.659 (0.50, 0.78) |
Unknown | 8 | 69.4 (SD 23) | 69.6 (SD 27) | 0.979 | 0.448 (−0.31, 0.86) |
PTSD symptoms& | |||||
No PTSD (IES < 35) | 629 | 84.9 (SD 13) | 86.1 (SD 12) | 0.003* | 0.655 (0.61–0.70) |
PTSD (IES > =35) | 111 | 78.4 (SD 17) | 79.0 (SD 19) | 0.869 | 0.495 (0.35, 0.62) |
Unknown | 320 | 81.5 (SD 17) | 83.5 (SD 15) | 0.022* | 0.515 (0.43, 0.59). |